Sovrenn Daily News - 11th Mar 2025
Cosmic CRF Ltd.
Recent filing: (FUND RAISE) Board had earlier, in Jan-2025, approved a fund raise of INR 264 Cr (13.2L equity shares and 3.2L warrants) at INR 1,614 each. In continuation of the same, it has now approved the allotment of 9.9L equity shares and 3.2L warrants at INR 1,614 each, aggregating to INR 211 Cr. Subscribers include Ashish Kacholia, Alchemy Long Term Ventures Fund, and Pooja Kedia. The allotment price is at a premium of 15% to the current share price.
SUMMARY: 2y Operating Profit uptrend | 4h Operating Profit uptrend | PE 45.9x (Sector PE range 40-70) | Capacity Expansion | Excellent Sep-24 results | | Order book stands at INR 520 Cr (Sep’24) (1.8x times of TTM Revenue) | Large Order | Institutional Entry | Promoter buying | Fund raising | Strategic acquisition | Railways
FUTURE OUTLOOK: As per H2FY24 Investor Presentation, Company is targeting a Consolidated Revenue of 500 Crore for the Upcoming Year and over the next five years, aiming to double top line, capacity, bottom line, and turnover.
- MCap of INR 1,147 Crore (share price = INR 1,399 / share) (as on 11th Mar ‘25)
- TTM PE of 45.9x (as on 11th Mar ‘25) Retail float = 16.0% (Sep-24)
FOOD FOR THOUGHT: Negative cash flow from operations in FY24
Stock price can go down or up based on market forces. Always diversify your portfolio.
Company Description: Cosmic Group is a name to reckon with in the business community in the eastern India. The group is active in various business/industries like cold rolled forming and manufacturing of other engineering items for wagon carts, electrical transmission and defense sector as well as real estate.
Discover Stocks for free in Sovrenn Discovery - Large Order Bucket
Vinyas Innovative Technologies Ltd.
Recent filing: (ORDER) Vinyas Innovative Technologies has received purchase orders worth INR 53.9 Cr from various domestic and international customers for the manufacture and supply of assembled PCBs. The contracts, awarded by both domestic and international entities, are expected to be executed within 12-18 months.
SUMMARY: 5y Operating Profit uptrend | PE 57.6x (Sector PE range 50-100) | Agreements | Asset Expansion | Capacity expansion | EMS
- MCap of INR 963 Crore (share price = INR 765 /share) (as on 11th Mar ‘25)
- TTM PE 57.6x (as on 11th Mar ‘25) Retail float = 10.7% (Sep-24)
FOOD FOR THOUGHT: Negative Operating cash flow for FY24.
Stock price can go down or up based on market forces. Always diversify your portfolio.
Company Description: Vinyas Innovative Technologies, established in 2001, is a leading provider of electronic manufacturing services for global OEMs and ODMs. Specializing in design, engineering, and manufacturing, Vinyas offers comprehensive solutions from design to turnkey requirements, utilizing cutting-edge technology and infrastructure. Recognized for innovation in the EMS industry, Vinyas delivers quality and integrity in its services, maintaining a global network of suppliers and customers. The company provides end-to-end solutions, including PCB assembly, supply chain management, and after-market support, making it a preferred partner for mission-critical applications.
Now get chance to learn investing for free at Sovrenn Education
Narayana Hrudayalaya Ltd.
Recent filing: (JOINT VENTURE) Health City Cayman Islands Ltd. (HCCI), the Company's wholly owned overseas subsidiary, entered into a joint venture on March 7, 2025, with 2070 Health Inc., W Health Ventures GP LLC, and Everhope Oncology Private Limited to establish cancer treatment centers in India, focusing on chemotherapy. The JV is structured as a 50:20:30 partnership between HCCI, 2070 Health, and W Health, respectively, with a total investment of $10 million (INR 87 Cr) over 1-2 years.
SUMMARY: 4y Operating Profit uptrend | 4q Operating Profit uptrend | PE 41x (Sector PE range 40-80) | New business line | Capacity expansion | Fund raise | Institutional Entry | Healthcare
- MCap of INR 32,075 Crore (share price = INR 1,570 / share) (as on 11th Mar ‘25)
- TTM PE of 41x (as on 11th Mar ‘25) Retail float = 10.3% (Dec-24)
FOOD FOR THOUGHT: Company has capex plans of INR 1,200 Cr for FY24/25, to be partly funded by debt
Stock price can go down or up based on market forces. Always diversify your portfolio.
Company Description: Narayana Health is headquartered in Bengaluru, India, and operates a network of hospitals across the country, with a particularly strong presence in the southern state of Karnataka and eastern India, as well as an emerging presence in northern, western, and central India. It provides advanced levels of care in over 30 specialties, including Cardiology and Cardiac Surgery, Cancer Care, Neurology and Neurosurgery, Orthopedics, Nephrology and Urology, and Gastroenterology.
